Director, Global HEOR – Top Boston Commercial-Stage Pharma - focus on high-profi
Cornerstone Search Group, Boston, MA, United States
Director, Global HEOR [ RETAINED SEARCH ]
Top Boston Commercial-Stage Pharma
focus on high-profile, clinical-stage, rare disease biologic with multiple indications
Cornerstone Search Group’s HEOR/Market Access Practice is pleased to be retained once again by a leading Boston-area pharmaceutical company renowned for operating at the forefront of scientific innovation, successfully launching multiple breakthrough medicines, and having top-notch talent. They are seeking a technically strong HEOR professional with very good communication skills for a newly created and critical Global HEOR position that will focus on a high-profile, first-in-class potential, clinical-stage biologic asset projected to be a multi-blockbuster with multiple and diverse immunology-related rare disease indications.
5 Highly Attractive Features:
High-Profile Impact:
This newly created, highly visible role focuses on a clinical-stage biologic that is potentially first-in-class, has multiple and diverse rare disease indication approval potential, and is anticipated to be a multi-blockbuster. Stable and Growing Company:
In an era of instability and staff cutbacks by companies of all sizes, our client’s scientific and strategic acumen has led to continued growth, providing organizational stability and demonstrated career progression for multiple HEOR professionals. Strong HEOR Leadership:
Our client’s HEOR department has steady, proven, high-EQ leadership whom we know quite well. Attractive to Directors
: Our client offers highly competitive compensation, LTI, relocation, and sign-on bonus programs along with a highly regarded department leader and a demonstrated history of internal career growth. This position can thus be very attractive to experienced HEOR Directors. Opportunity to Gain Global Experience
: Our client is willing to consider a high-potential individual who does not yet have strong global experience as the hiring manager has such experience and is a willing mentor.
Key Accountabilities: Develop HEOR strategy for multiple immunology / auto-immune indications ranging from early development through product lifecycle. Work with cross-functional and cross-regional teams to align strategic plans. Gather and synthesize insights from Payers and KOLs. Plan, design, and execute HEOR evidence generation including observational studies (prospective and retroactive), CEA and BIM, ITCs, meta-analyses and systematic reviews, and COA/PRO. Supports the integration of HEOR evidence in HTA submissions. Collaborates cross-functionally on publication strategy and HEOR evidence dissemination. Partner closely with your global pricing and global market access colleagues to support production of global value dossier.
Location:
Boston Metro Area - 3 days per week on-site is required
Relocation:
Full relocation assistance is available.
Compensation:
Highly competitive base and bonus along with aggressive LTI program, generous PTO, and excellent benefits.
Desired Skills/ Qualifications / Experiences / Behaviors: MA/MS, MPH, PharmD, PhD, or MD 5+ years of relevant experience Strategic and analytical thinker who can connect clinical-stage evidence generation activities to business and clinical priorities. A hands-on project leader with strong execution skills and attention to detail. A track record of formulating and leading creative and scientifically rigorous research projects. Technical strengths in data analytics, database research, RWE, and outcomes research. Experience preparing publications and presenting scientific findings. Our client does not require therapeutic areas of experience. High EQ (emotional intelligence) coupled with persuasive communication, presentation, and influencing skills across internal and external stakeholders.
CONTACT:
Rita Boyle | Partner rboyle@cornerstonesg.com www.linkedin.com/in/ritaboyle 973.656.0220 x735 or Corey S. Ackerman, JD | Senior Partner cackerman@cornerstonesg.com www.linkedin.com/in/coreyackerman 973.656.0220 x716
CORNERSTONE SEARCH GROUP
- Life Sciences Executive Search 1200 Morris Turnpike, Suite 3005 | Short Hills, NJ (USA)
Cornerstone Search Group, recognized by Forbes as one of the "Top 100 Executive Search Firms" and by Hunt Scanlon as one of the "Top 50 Healthcare & Life Sciences Executive Search Firms", is a Life Sciences Executive Search firm that helps companies based around the world, ranging from startup biotechs to Top 10 pharma, to find, attract, and hire talent for their US and globally based leadership positions (CxO and xVP levels) as well as their critical Director-level roles.
Representative Retained Search Assignments: CEO | specialty pharma start-up CEO | regenerative medicine start-up US CEO | established European small pharma President/US Commercial Head | Generics Pharma CMO | late-stage public biotech CMO | mid-size pharma CSO | mid-size global biotech SVP, Head of Global Medical Affairs | mid-size oncology company SVP, Head of Global Clinical Development | multi-TA mid-size pharma SVP, Head of Global Regulatory Affairs | late-stage Israeli biotech Global Head, Oncology R&D | mid-size European pharma Group VP, Global Commercial Head | API Business Unit | Indian pharma VP, Data Science RWE | Top 5 Pharma VP, Head of Regulatory Affairs | Boston Biotech VP, US Head of Regulatory Affairs | Top 20 Pharma VP, Head of R&D Operations | Boston biotech VP, Head of HEOR (Health Economics & Outcomes Research | Top CNS specialty pharma VP, Head of US HEOR & RWE | Top 5 Pharma VP, Head of Real-World Evidence | Top 5 pharma VP, Head of US HEOR | Top Oncology Pharma ED, Head of HEOR | Top West Coast Pharma VP, Head of Global Market Access | Top Oncology Specialty Pharma VP, Head of US Market Access | High-profile late-stage biotech VP, Head of US Market Access | West Coast Late-Stage Public Biotech VP, Head of Heme/Onc Clinical Research | Public oncology biotech VP, Head of Clinical Development | late-stage anti-infectives UK pharma VP, Head of Global Drug Safety & PV | Chinese oncology biotech ED, Head of Clinical Operations | British VC-backed biotech ED, Global Commercial Strategy Franchise Head | Top rare disease Boston pharma ED, Head of Global Clinical Pharmacology | Public oncology biotech ED, Head of Global HEOR | Large US Pharma Head, Patient Advocacy | European commercial-stage rare disease biotech Medical Directors (Director/SD/ED levels) in Translational Medicine / Clinical Development / Medical Affairs / Drug Safety: 75+ retained assignments HEOR/RWE/Market Access (AD/Director/SD/ED levels): 100+ retained assignments
Cornerstone’s Privacy Policy:
Cornerstone Search Group considers all inquiries, resume submissions, and any other personal information submitted to us as confidential information. This information will not be shared with any parties outside of Cornerstone Search Group without your prior permission.
Keywords:
GHEOR “Health Economics” “Real-World Evidence” RWE ITC “indirect treatment comparison” “rare disease” HEOR GHE HE&OR “HE & OR” “Health Outcomes”
Cornerstone Search Group’s HEOR/Market Access Practice is pleased to be retained once again by a leading Boston-area pharmaceutical company renowned for operating at the forefront of scientific innovation, successfully launching multiple breakthrough medicines, and having top-notch talent. They are seeking a technically strong HEOR professional with very good communication skills for a newly created and critical Global HEOR position that will focus on a high-profile, first-in-class potential, clinical-stage biologic asset projected to be a multi-blockbuster with multiple and diverse immunology-related rare disease indications.
5 Highly Attractive Features:
High-Profile Impact:
This newly created, highly visible role focuses on a clinical-stage biologic that is potentially first-in-class, has multiple and diverse rare disease indication approval potential, and is anticipated to be a multi-blockbuster. Stable and Growing Company:
In an era of instability and staff cutbacks by companies of all sizes, our client’s scientific and strategic acumen has led to continued growth, providing organizational stability and demonstrated career progression for multiple HEOR professionals. Strong HEOR Leadership:
Our client’s HEOR department has steady, proven, high-EQ leadership whom we know quite well. Attractive to Directors
: Our client offers highly competitive compensation, LTI, relocation, and sign-on bonus programs along with a highly regarded department leader and a demonstrated history of internal career growth. This position can thus be very attractive to experienced HEOR Directors. Opportunity to Gain Global Experience
: Our client is willing to consider a high-potential individual who does not yet have strong global experience as the hiring manager has such experience and is a willing mentor.
Key Accountabilities: Develop HEOR strategy for multiple immunology / auto-immune indications ranging from early development through product lifecycle. Work with cross-functional and cross-regional teams to align strategic plans. Gather and synthesize insights from Payers and KOLs. Plan, design, and execute HEOR evidence generation including observational studies (prospective and retroactive), CEA and BIM, ITCs, meta-analyses and systematic reviews, and COA/PRO. Supports the integration of HEOR evidence in HTA submissions. Collaborates cross-functionally on publication strategy and HEOR evidence dissemination. Partner closely with your global pricing and global market access colleagues to support production of global value dossier.
Location:
Boston Metro Area - 3 days per week on-site is required
Relocation:
Full relocation assistance is available.
Compensation:
Highly competitive base and bonus along with aggressive LTI program, generous PTO, and excellent benefits.
Desired Skills/ Qualifications / Experiences / Behaviors: MA/MS, MPH, PharmD, PhD, or MD 5+ years of relevant experience Strategic and analytical thinker who can connect clinical-stage evidence generation activities to business and clinical priorities. A hands-on project leader with strong execution skills and attention to detail. A track record of formulating and leading creative and scientifically rigorous research projects. Technical strengths in data analytics, database research, RWE, and outcomes research. Experience preparing publications and presenting scientific findings. Our client does not require therapeutic areas of experience. High EQ (emotional intelligence) coupled with persuasive communication, presentation, and influencing skills across internal and external stakeholders.
CONTACT:
Rita Boyle | Partner rboyle@cornerstonesg.com www.linkedin.com/in/ritaboyle 973.656.0220 x735 or Corey S. Ackerman, JD | Senior Partner cackerman@cornerstonesg.com www.linkedin.com/in/coreyackerman 973.656.0220 x716
CORNERSTONE SEARCH GROUP
- Life Sciences Executive Search 1200 Morris Turnpike, Suite 3005 | Short Hills, NJ (USA)
Cornerstone Search Group, recognized by Forbes as one of the "Top 100 Executive Search Firms" and by Hunt Scanlon as one of the "Top 50 Healthcare & Life Sciences Executive Search Firms", is a Life Sciences Executive Search firm that helps companies based around the world, ranging from startup biotechs to Top 10 pharma, to find, attract, and hire talent for their US and globally based leadership positions (CxO and xVP levels) as well as their critical Director-level roles.
Representative Retained Search Assignments: CEO | specialty pharma start-up CEO | regenerative medicine start-up US CEO | established European small pharma President/US Commercial Head | Generics Pharma CMO | late-stage public biotech CMO | mid-size pharma CSO | mid-size global biotech SVP, Head of Global Medical Affairs | mid-size oncology company SVP, Head of Global Clinical Development | multi-TA mid-size pharma SVP, Head of Global Regulatory Affairs | late-stage Israeli biotech Global Head, Oncology R&D | mid-size European pharma Group VP, Global Commercial Head | API Business Unit | Indian pharma VP, Data Science RWE | Top 5 Pharma VP, Head of Regulatory Affairs | Boston Biotech VP, US Head of Regulatory Affairs | Top 20 Pharma VP, Head of R&D Operations | Boston biotech VP, Head of HEOR (Health Economics & Outcomes Research | Top CNS specialty pharma VP, Head of US HEOR & RWE | Top 5 Pharma VP, Head of Real-World Evidence | Top 5 pharma VP, Head of US HEOR | Top Oncology Pharma ED, Head of HEOR | Top West Coast Pharma VP, Head of Global Market Access | Top Oncology Specialty Pharma VP, Head of US Market Access | High-profile late-stage biotech VP, Head of US Market Access | West Coast Late-Stage Public Biotech VP, Head of Heme/Onc Clinical Research | Public oncology biotech VP, Head of Clinical Development | late-stage anti-infectives UK pharma VP, Head of Global Drug Safety & PV | Chinese oncology biotech ED, Head of Clinical Operations | British VC-backed biotech ED, Global Commercial Strategy Franchise Head | Top rare disease Boston pharma ED, Head of Global Clinical Pharmacology | Public oncology biotech ED, Head of Global HEOR | Large US Pharma Head, Patient Advocacy | European commercial-stage rare disease biotech Medical Directors (Director/SD/ED levels) in Translational Medicine / Clinical Development / Medical Affairs / Drug Safety: 75+ retained assignments HEOR/RWE/Market Access (AD/Director/SD/ED levels): 100+ retained assignments
Cornerstone’s Privacy Policy:
Cornerstone Search Group considers all inquiries, resume submissions, and any other personal information submitted to us as confidential information. This information will not be shared with any parties outside of Cornerstone Search Group without your prior permission.
Keywords:
GHEOR “Health Economics” “Real-World Evidence” RWE ITC “indirect treatment comparison” “rare disease” HEOR GHE HE&OR “HE & OR” “Health Outcomes”